152 related articles for article (PubMed ID: 6943371)
41. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
42. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
43. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
44. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
45. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
46. Phenotypical and functional analyses of natural killer cells from low NK activity individuals among healthy and patient populations.
Nagao F; Yabe T; Xu M; Okumura K
Nat Immun; 1995 Sep; 14(5-6):225-33. PubMed ID: 8933817
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity.
Badger AM; Oh SK; Moolten FR
Cancer Res; 1981 Mar; 41(3):1133-9. PubMed ID: 7193084
[TBL] [Abstract][Full Text] [Related]
48. Extremely low frequency-magnetic fields (ELF-EMF) occupational exposure and natural killer activity in peripheral blood lymphocytes.
Gobba F; Bargellini A; Scaringi M; Bravo G; Borella P
Sci Total Environ; 2009 Jan; 407(3):1218-23. PubMed ID: 18804846
[TBL] [Abstract][Full Text] [Related]
49. A new analysis of natural killing activity and the role of monocytes in normal subjects.
Ono K; Shimamoto Y; Nishimura J; Yamaguchi M; Nawata H
J Clin Lab Immunol; 1989 Dec; 30(4):175-81. PubMed ID: 2534974
[TBL] [Abstract][Full Text] [Related]
50. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
51. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
Melioli G; Ferrari I; Casartelli G; Ragni N
Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
[TBL] [Abstract][Full Text] [Related]
52. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
53. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Vujanovic NL; Rabinowich H; Lee YJ; Jost L; Herberman RB; Whiteside TL
Cell Immunol; 1993 Oct; 151(1):133-57. PubMed ID: 8402925
[TBL] [Abstract][Full Text] [Related]
54. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity within the population of NK and K cells.
Jensen PJ; Koren HS
J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
[TBL] [Abstract][Full Text] [Related]
56. [The significance of determination of NK cell activity in malignant diseases].
Spuzić I; Konjević G
Glas Srp Akad Nauka Med; 1990; (39):153-60. PubMed ID: 2130019
[TBL] [Abstract][Full Text] [Related]
57. [Natural killer activity in patients with malignant melanoma].
Masserini C; Villa ML; Rovini D; Clerici E
Boll Ist Sieroter Milan; 1981; 60(4):307-15. PubMed ID: 7326104
[TBL] [Abstract][Full Text] [Related]
58. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
Peoples GE; Goedegebuure PS; Andrews JV; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5481-91. PubMed ID: 8228240
[TBL] [Abstract][Full Text] [Related]
59. Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.
Stavrou D; Bilzer T; Anzil AP; Hultén M; Kaldrymidou E
Anticancer Res; 1981; 1(3):125-34. PubMed ID: 7342850
[TBL] [Abstract][Full Text] [Related]
60. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
